The scientist’s investigation covers issues in Biochemistry, Cholesterol, Internal medicine, Lipoprotein and Endocrinology. His work on Cholesteryl ester, High-density lipoprotein and Intermediate-density lipoprotein is typically connected to Low density as part of general Cholesterol study, connecting several disciplines of science. He interconnects Immunology and Cryptosporidium in the investigation of issues within Internal medicine.
His Lipoprotein study incorporates themes from Blood plasma and Metabolism. His Endocrinology research includes elements of Unsaturated fatty acid and Food science. His Very low-density lipoprotein study deals with Lipoprotein lipase intersecting with Triglyceride, Chylomicron, Phospholipid and Stimulation.
His primary scientific interests are in Internal medicine, Endocrinology, Biochemistry, Cholesterol and Triglyceride. Internal medicine is frequently linked to Gastroenterology in his study. As part of his studies on Endocrinology, Richard J. Deckelbaum frequently links adjacent subjects like Apolipoprotein E.
Richard J. Deckelbaum studied Biochemistry and Fish oil that intersect with Food science, Eicosapentaenoic acid and Catabolism. Richard J. Deckelbaum combines topics linked to Human plasma with his work on Cholesterol. The concepts of his Lipoprotein lipase study are interwoven with issues in Chylomicron and Lipolysis.
His main research concerns Internal medicine, Endocrinology, Biochemistry, Polyunsaturated fatty acid and Lipoprotein lipase. His Endocrinology and Triglyceride and Cholesterol investigations all form part of his Endocrinology research activities. His work on Biochemistry is being expanded to include thematically relevant topics such as In vivo.
His studies in Lipoprotein lipase integrate themes in fields like Chylomicron, Very low-density lipoprotein, Bone marrow and Lipolysis. Richard J. Deckelbaum usually deals with Eicosapentaenoic acid and limits it to topics linked to Chromatography and Emulsion. Richard J. Deckelbaum combines subjects such as Lipoprotein and Pharmacology with his study of In vitro.
Endocrinology, Internal medicine, Biochemistry, Polyunsaturated fatty acid and Eicosapentaenoic acid are his primary areas of study. His study in Endocrinology is interdisciplinary in nature, drawing from both Inflammation and Fatty acid. Internal medicine is closely attributed to Lactation in his research.
His work on Wound healing expands to the thematically related Biochemistry. His Eicosapentaenoic acid research is multidisciplinary, incorporating elements of Soybean oil, Linoleic acid, Docosahexaenoic acid, Omega 3 fatty acid and Fish oil. His study explores the link between Lipoprotein lipase and topics such as Cholesterol that cross with problems in Nutrient and Diabetes mellitus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
AHA Dietary Guidelines Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association
Ronald M. Krauss;Robert H. Eckel;Barbara Howard;Lawrence J. Appel.
Circulation (2000)
Childhood obesity: the health issue.
Richard J. Deckelbaum;Christine L. Williams.
Obesity Research (2001)
Structure and interactions of lipids in human plasma low density lipoproteins.
R J Deckelbaum;G G Shipley;D M Small.
Journal of Biological Chemistry (1977)
n−3 Fatty acids and gene expression
Richard J Deckelbaum;Tilla S Worgall;Toru Seo.
The American Journal of Clinical Nutrition (2006)
Plasma triglyceride determines structure-composition in low and high density lipoproteins.
R J Deckelbaum;E Granot;Y Oschry;L Rose.
Arteriosclerosis, Thrombosis, and Vascular Biology (1984)
Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
S Eisenberg;D Gavish;Y Oschry;M Fainaru.
Journal of Clinical Investigation (1984)
Sterol Esterification in Yeast: A Two-Gene Process
Hongyuan Yang;Martin Bard;Debora A. Bruner;Anne Gleeson.
Science (1996)
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia.
Jun-Shan Liang;Oliver Distler;Oliver Distler;David A. Cooper;Haris Jamil.
Nature Medicine (2001)
Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity
Narmer F. Galeano;Maysoon Al-Haideri;Fannie Keyserman;Steven C. Rumsey.
Journal of Lipid Research (1998)
AHA scientific statement: AHA dietary guidelines: Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association
Ronald M. Krauss;Robert H. Eckel;Barbara Howard;Lawrence J. Appel.
Journal of Nutrition (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Southampton
New York University
Umeå University
Columbia University
Columbia University
KTH Royal Institute of Technology
Ben-Gurion University of the Negev
Columbia University Medical Center
Johns Hopkins University
Boston University
Hang Seng University of Hong Kong
Ben-Gurion University of the Negev
MIT
Uppsala University
University of Southern California
University of California, San Diego
North Carolina State University
University of Arkansas at Fayetteville
McGill University
Lund University
Amgen (United States)
Ehime University
Australian National University
University of Florence
University of Amsterdam
University of Zurich